Efficacy and Safety of Denosumab Therapy for Osteogenesis Imperfecta Patients with Osteoporosis—Case Series

Osteogenesis imperfecta (OI) is a connective tissue disorder that is characterized by low bone density leading to recurrent fractures. The efficacy of the anti-resorption drug denosumab for OI with osteoporosis is still largely unknown. We herein describe the clinical outcomes of eight osteoporotic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Tsukasa, Nakamura, Yukio, Suzuki, Takako, Yamaguchi, Tomomi, Takeda, Ryojun, Takagi, Masaki, Hasegawa, Tomonobu, Kosho, Tomoki, Kato, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306860/
https://www.ncbi.nlm.nih.gov/pubmed/30477250
http://dx.doi.org/10.3390/jcm7120479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306860/
https://www.ncbi.nlm.nih.gov/pubmed/30477250
http://dx.doi.org/10.3390/jcm7120479

Ejemplares similares